Payment overview · 2025
General Payments
$98.46
1 reported records · 1 companies
Healthcare provider profile · identity verified
Megan Jackson
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · KENDALLVILLE, IN · NPI 1952778375
Verified facts
What the public records show
CMS Open Payments records show Megan Jackson received $98.46 in general payments during 2025 across 1 reported records.
Neurocrine BioSciences, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $98.46 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $98.46 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $98.46 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 455 | 75 |
| Potassium Chloride | Potassium Chloride | 454 | 105 |
| Gabapentin | Gabapentin | 430 | 68 |
| Levothyroxine Sodium | Levothyroxine Sodium | 419 | 64 |
| Atorvastatin Calcium | Atorvastatin Calcium | 361 | 64 |
| Memantine Hcl | Memantine Hcl | 293 | 43 |
| Torsemide | Torsemide | 281 | 55 |
| Furosemide | Furosemide | 260 | 51 |
| Donepezil Hcl | Donepezil Hcl | 249 | 37 |
| Amlodipine Besylate | Amlodipine Besylate | 241 | 37 |
| Jardiance | Empagliflozin | 241 | 32 |
| Tamsulosin Hcl | Tamsulosin Hcl | 238 | 40 |
| Omeprazole | Omeprazole | 214 | 52 |
| Losartan Potassium | Losartan Potassium | 209 | 36 |
| Eliquis | Apixaban | 192 | 24 |
| Tramadol Hcl | Tramadol Hcl | 187 | 46 |
| Pantoprazole Sodium | Pantoprazole Sodium | 186 | 41 |
| Methenamine Hippurate | Methenamine Hippurate | 175 | 32 |
| Pregabalin | Pregabalin | 160 | 20 |
| Metoprolol Succinate | Metoprolol Succinate | 159 | 27 |
| Sertraline Hcl | Sertraline Hcl | 158 | 35 |
| Famotidine | Famotidine | 155 | 31 |
| Metoprolol Tartrate | Metoprolol Tartrate | 151 | 35 |
| Prednisone | Prednisone | 142 | 98 |
| Lisinopril | Lisinopril | 140 | 29 |
| Lactulose | Lactulose | 128 | 20 |
| Clopidogrel | Clopidogrel Bisulfate | 120 | 16 |
| Trazodone Hcl | Trazodone Hcl | 110 | 18 |
| Warfarin Sodium | Warfarin Sodium | 105 | suppressed |
| Metformin Hcl | Metformin Hcl | 104 | 28 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 91 | 14 |
| Gemtesa | Vibegron | 90 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 87 | 49 |
| Azelastine Hcl | Azelastine Hcl | 86 | 34 |
| Escitalopram Oxalate | Escitalopram Oxalate | 84 | 12 |
| Cephalexin | Cephalexin | 81 | 62 |
| Mirtazapine | Mirtazapine | 81 | 26 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 78 | 22 |
| Fluticasone Propionate | Fluticasone Propionate | 77 | 27 |
| Buspirone Hcl | Buspirone Hcl | 75 | 12 |
| Carvedilol | Carvedilol | 74 | 21 |
| Citalopram Hbr | Citalopram Hydrobromide | 73 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 73 | 55 |
| Hydralazine Hcl | Hydralazine Hcl | 72 | 24 |
| Finasteride | Finasteride | 71 | suppressed |
| Spironolactone | Spironolactone | 71 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 70 | 13 |
| Oxycodone Hcl | Oxycodone Hcl | 64 | 17 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 61 | 42 |
| Montelukast Sodium | Montelukast Sodium | 57 | suppressed |
| Trulicity | Dulaglutide | 57 | 16 |
| Aripiprazole | Aripiprazole | 56 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 53 | 38 |
| Hydrochlorothiazide | Hydrochlorothiazide | 53 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 52 | 34 |
| Divalproex Sodium | Divalproex Sodium | 51 | 11 |
| Insulin Lispro | Insulin Lispro | 51 | 18 |
| Prenatal Vitamin Plus Low Iron | Pnv,calcium 72/Iron/Folic Acid | 51 | 12 |
| Sucralfate | Sucralfate | 51 | suppressed |
| Baclofen | Baclofen | 49 | 13 |
| Olanzapine | Olanzapine | 49 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 47 | 35 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 47 | 22 |
| Nystatin | Nystatin | 47 | 39 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 47 | suppressed |
| Lorazepam | Lorazepam | 46 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 44 | 18 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 43 | 18 |
| Topiramate | Topiramate | 43 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 42 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 42 | 19 |
| Meloxicam | Meloxicam | 42 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 40 | suppressed |
| Fentanyl | Fentanyl | 40 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 40 | 30 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 39 | suppressed |
| Risperidone | Risperidone | 39 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 39 | suppressed |
| Fluconazole | Fluconazole | 38 | 26 |
| Metoclopramide Hcl | Metoclopramide Hcl | 38 | 13 |
| Morphine Sulfate | Morphine Sulfate | 38 | 18 |
| Allopurinol | Allopurinol | 37 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 36 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 35 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 35 | 15 |
| Ozempic | Semaglutide | 34 | suppressed |
| Xarelto | Rivaroxaban | 34 | suppressed |
| Digoxin | Digoxin | 33 | suppressed |
| Brilinta | Ticagrelor | 32 | suppressed |
| Levetiracetam | Levetiracetam | 32 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 32 | 12 |
| Linzess | Linaclotide | 31 | suppressed |
| Myrbetriq | Mirabegron | 31 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 31 | 24 |
| Simvastatin | Simvastatin | 30 | suppressed |
| Ibuprofen | Ibuprofen | 29 | 16 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 29 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 28 | suppressed |
| Alprazolam | Alprazolam | 27 | suppressed |
| Diazepam | Diazepam | 27 | suppressed |
| Synthroid | Levothyroxine Sodium | 27 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 26 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 26 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 26 | suppressed |
| Lacosamide | Lacosamide | 26 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 24 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 24 | 21 |
| Ezetimibe | Ezetimibe | 23 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 23 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 22 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 22 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 22 | suppressed |
| Lovastatin | Lovastatin | 22 | suppressed |
| Tradjenta | Linagliptin | 22 | suppressed |
| Novolog | Insulin Aspart | 21 | suppressed |
| Telmisartan | Telmisartan | 21 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 20 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Tresiba | Insulin Degludec | 20 | suppressed |
| Insulin Aspart | Insulin Aspart | 19 | 11 |
| Ketoconazole | Ketoconazole | 19 | 12 |
| Pravastatin Sodium | Pravastatin Sodium | 19 | suppressed |
| Rivastigmine | Rivastigmine | 19 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 18 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 18 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 18 | suppressed |
| Ranolazine Er | Ranolazine | 18 | suppressed |
| Scopolamine | Scopolamine | 18 | suppressed |
| Solu-Medrol | Methylprednisolone Sod Succ/Pf | 18 | 16 |
| Acetic Acid | Acetic Acid | 17 | suppressed |
| Amoxicillin | Amoxicillin | 17 | 16 |
| Dicyclomine Hcl | Dicyclomine Hcl | 17 | suppressed |
| Humalog | Insulin Lispro | 17 | suppressed |
| Latanoprost | Latanoprost | 17 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 17 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 17 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 17 | suppressed |
| Primidone | Primidone | 17 | suppressed |
| Acyclovir | Acyclovir | 16 | suppressed |
| Carbamazepine | Carbamazepine | 16 | suppressed |
| Clonidine | Clonidine | 16 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 16 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 16 | suppressed |
| Vascepa | Icosapent Ethyl | 16 | suppressed |
| Amlodipine-Atorvastatin | Amlodipine/Atorvastatin | 15 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 15 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 15 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 15 | suppressed |
| Cilostazol | Cilostazol | 15 | suppressed |
| Cimetidine | Cimetidine | 15 | suppressed |
| Levofloxacin | Levofloxacin | 15 | 13 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 15 | 13 |
| Phenobarbital | Phenobarbital | 15 | suppressed |
| Erythromycin | Erythromycin Base | 14 | 12 |
| Glipizide | Glipizide | 14 | suppressed |
| Haloperidol | Haloperidol | 14 | suppressed |
| Loperamide | Loperamide Hcl | 14 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 14 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 14 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 13 | suppressed |
| Amantadine | Amantadine Hcl | 13 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 13 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 13 | suppressed |
| Clonazepam | Clonazepam | 12 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 12 | suppressed |
| Folic Acid | Folic Acid | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | 11 |
| Januvia | Sitagliptin Phosphate | 12 | suppressed |
| Lorazepam Intensol | Lorazepam | 12 | 12 |
| Trifluoperazine Hcl | Trifluoperazine Hcl | 12 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 12 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 11 | suppressed |
| Briviact | Brivaracetam | 11 | suppressed |
| Entresto | Sacubitril/Valsartan | 11 | suppressed |
| Galantamine Er | Galantamine Hbr | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $98.46 · 1 records | Neurocrine BioSciences, Inc. | INGREZZA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error